Moderna announced IND Submitted to FDA for phase 2 study of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
On Apr. 27, 2020, iBio announced it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL),…
On Apr. 27, 2020, Ichor announced that its TriGrid Delivery System is being utilized for delivery in non-human…
On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…
On Apr. 23, 2020, Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical of Johnson & Johnson…
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
On Apr. 22, 2020, Tyson Fresh Meats, the beef and pork subsidiary of Tyson Food, planned to indefinitely…
On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
On Apr. 21, 2020, Tyson Fresh Meats resumed limited operations at its pork plant in Columbus Junction, Iowa,…
On Apr. 20, 2020, VGX signed as the first occupant of Conroeメs Deison Technology Park and will move…
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
On Apr. 15, 2020, scientists at the University of Alberta have shown that the drug remdesivir is highly…
On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…
On Apr. 15, 2020, HALIX announced it had joined a consortium of partners under the guidance of the…
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced additional coronavirus…
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…